BloodFlow secures €1.2M seed funding to transform blood test analysis
Summary
BloodFlow has raised €1.2 million in seed funding to scale its platform that turns routine blood test results into immediate clinical insights. The company plugs into hospital systems through an API and focuses on accurate, explainable interpretation of blood diagnostics. It says the platform has already analyzed more than 50,000 patient reports and cut clinician review and transcription time by 95%. The new capital will support hiring, market expansion, and a clinical study aimed at medical device certification. BloodFlow also plans to broaden its commercial use cases, including support for pharmaceutical clinical trials.
Funding
Amount
$1.3M
Total raised
Date
July 25, 2025
Announcement date
Investors
-
Lead investors
Company
bloodflow.eu
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected